Hemostatic indices for patients II.1 and II.2
. | . | Patient . | . | |
|---|---|---|---|---|
| Test . | Normal range . | II.1 . | II.2 . | |
| Fibrinogen (clottable), mg/mL | 1.5-3.5 | 0.3 | 0.3 | |
| Fibrinogen (total), mg/mL | 1.5-3.5 | ND | 0.5 | |
| APTT, sec | 22-30 | 30 | 34 | |
| PT, sec | 11-13 | 22 | 21 | |
| TT, sec | 16-18 | 46 | 52 | |
| Whole blood clotting time, min | 3-8 | 15 | 10 | |
| Plasma clot lysis time, min | 27 | 101 | 104 | |
| Compressed clot, mm | 0.8-1.0* | ND | 1.6 | |
| t-PA, ng/mL | 4-6 | 6 | 12 | |
| PAI-1, ng/mL | 8-28 | 18 | 48 | |
| Platelet count/μL, × 10-3 | 150-400 | 218 | 242 | |
| FVIII, % | 55-183 | 197 | 178 | |
| FIX, % | 50-150 | 70 | 95 | |
| FXI, % | 56-164 | 92 | 100 | |
. | . | Patient . | . | |
|---|---|---|---|---|
| Test . | Normal range . | II.1 . | II.2 . | |
| Fibrinogen (clottable), mg/mL | 1.5-3.5 | 0.3 | 0.3 | |
| Fibrinogen (total), mg/mL | 1.5-3.5 | ND | 0.5 | |
| APTT, sec | 22-30 | 30 | 34 | |
| PT, sec | 11-13 | 22 | 21 | |
| TT, sec | 16-18 | 46 | 52 | |
| Whole blood clotting time, min | 3-8 | 15 | 10 | |
| Plasma clot lysis time, min | 27 | 101 | 104 | |
| Compressed clot, mm | 0.8-1.0* | ND | 1.6 | |
| t-PA, ng/mL | 4-6 | 6 | 12 | |
| PAI-1, ng/mL | 8-28 | 18 | 48 | |
| Platelet count/μL, × 10-3 | 150-400 | 218 | 242 | |
| FVIII, % | 55-183 | 197 | 178 | |
| FIX, % | 50-150 | 70 | 95 | |
| FXI, % | 56-164 | 92 | 100 | |
Normal plasma (fibrinogen = 2-3 mg/mL). Clots from normal plasma, diluted to 0.3 mg/mL with defibrinogenated plasma, were compressed to 0.007 mm. ND indicates not determined